Also from this source

You just read:

Argos Therapeutics Initiates Dosing of Patients in Phase 1 Clinical Trial of Monoclonal Antibody-Based Therapy for Treatment of Systemic Lupus Erythematosus

News provided by

Argos Therapeutics, Inc.

Dec 07, 2010, 08:00 EST